US court dismisses Lipitor whistleblower suit against Pfizer
28 May 2009
Nancy Faigen
A US federal judge has granted
Pfizer's request to dismiss a former employee's
qui tam lawsuit alleging that the company pursued an "off-label marketing scheme" for its hypolipaemic Lipitor (atorvastatin), resulting in false claims being submitted for reimbursement by federal and state health...
Please Login to read the full article.
28 May 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
